CN101023990B - Chinese readymade medicine for treating exogenous disease - Google Patents

Chinese readymade medicine for treating exogenous disease Download PDF

Info

Publication number
CN101023990B
CN101023990B CN200710010760A CN200710010760A CN101023990B CN 101023990 B CN101023990 B CN 101023990B CN 200710010760 A CN200710010760 A CN 200710010760A CN 200710010760 A CN200710010760 A CN 200710010760A CN 101023990 B CN101023990 B CN 101023990B
Authority
CN
China
Prior art keywords
medicine
herba
chinese
radix
chinese patent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN200710010760A
Other languages
Chinese (zh)
Other versions
CN101023990A (en
Inventor
刘景君
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN200710010760A priority Critical patent/CN101023990B/en
Publication of CN101023990A publication Critical patent/CN101023990A/en
Application granted granted Critical
Publication of CN101023990B publication Critical patent/CN101023990B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The present invention relates to a Chinese patent medicine for effectively curing diseases due to exopathy. It is made up by using 8 Chinese medicinal materials of elsholtzia, schizonepeta spike, coriander, dehurian angelica root, bupleurum root, scutellaria root, forsythia process. Said medicine can be made into oral preparation and belly-button adhesive plaster preparation.

Description

A kind of Chinese patent medicine for the treatment of exterior syndrome
Technical field
The present invention relates to treat the Chinese patent medicine of exterior syndrome, is the Chinese patent medicine of a kind of oral and umbilical external application administration simultaneously.
Background technology
Exterior syndrome---being commonly called as flu, is the disease kind that morbidity risk rate is the highest in the human diseases, is multiple throughout the year disease, and numerous disease is arranged is to be caused by diseases caused by exogenous pathogenic factor.At present also seldom having efficiently, the Chinese patent medicine of main flow is used for controlling this four seasons frequently-occurring disease of diseases caused by exogenous pathogenic factor.Therefore, people are also just with a little Western medicine or Chinese and Western synthetic drug; The clothes Chinese herbal medicine decoction is not extensively taken owing to pretty troublesome yet; Generally in vogue is the venous transfusion administration, makes that antibiotic and hormone are abused in a large number, not only consuming time many, costs an arm and a leg, also not satisfactory with regard to its curative effect, and various side effect also often take place.In a word, the multiple medicine of many treatment exterior syndromes is arranged on the market, certain pluses and minuses are respectively arranged.
Summary of the invention
The purpose of this invention is to provide a kind of easy to use, have a better curative effect, seldom toxic and side effects, cheap Chinese patent medicine.One side is dual-purpose for this medicine, promptly makes oral and two kinds of dosage forms of external application, is again oral and the simultaneously applied cover Chinese patent medicine of external application two parts.Share inside and outside the cause, efficacy of a drug abundance takes effect rapidly, and it is very fast to recover.This Herba Achnatheri Inebriantis children is all suitable, if the oral inconvenient person of infant also can singly use the external application part, effect is also satisfactory.
The objective of the invention is to realize by following scheme:
Medicine of the present invention is made by following component: (consumption is a weight portion)
Herba Moslae 30~40 Herba Schizonepetae 20~30 Herba Coriandris 10~20 Radixs Angelicae Dahuricae 20~30
Radix Bupleuri 10~20 Radix Scutellariaes 20~30 Fructus Forsythiaes 10~20 Radix Glycyrrhizae 5~10
The optimum weight of medicine of the present invention (part) proportioning is:
Herba Moslae 35 Herba Schizonepetae 25 Herba Coriandris 15 Radixs Angelicae Dahuricae 25
Radix Bupleuri 15 Radix Scutellariaes 25 Fructus Forsythiaes 15 Radix Glycyrrhizae 7.5
Above-mentioned materials of weight proportions is made medicine production method of the present invention is: can Chinese patent medicine medicine manufacture method routinely make.Select the first-class medical material of quality, remove impurity, the pulverizing that is mixed is fully stirred, sterilization, and packing is made generally in the watered pill or honeyed pill.No matter all contain pure dried medicated powder 8 grams in the watered pill or each fractional pack of honeyed pill, optional bottled or bag packing.As the once oral dose of adult.
Clinical drug of the present invention uses the result to show that following advantage is arranged:
1, to select the natural vegetable Chinese herbal medicine material for use be raw material in the present invention, utilizes the comprehensive function treatment exterior syndrome of the Chinese medicine of respectively distinguishing the flavor of, and do not mix chemical agent, and human body is had no side effect; Cost is lower, is easily accepted by the patient.
2, the present invention is oral and umbilical external application administration simultaneously, efficacy of a drug abundance, takes effect rapidly, and it is fast to recover, this Herba Achnatheri Inebriantis children is all suitable, if the oral extremely inconvenient person of infant also can singly use the umbilical external application dosage form, effect is also satisfactory, has solved the big problem that it is difficult that infant is taken medicine.
3, use medicine therapy of the present invention, the healing process required time is compared with other medicines, and the time spent obviously shortens, and the lighter can cure about one day, and heavy person also only cured on the two to three.Owing to cure soon, avoided some concurrent and generations secondary disease, easy to use, also saved the plenty of time for people.
The specific embodiment
Embodiment
Take by weighing raw material (gram) by following proportioning:
Herba Moslae 35 Herba Schizonepetae 25 Herba Coriandris 15 Radixs Angelicae Dahuricae 25
Radix Bupleuri 15 Radix Scutellariaes 25 Fructus Forsythiaes 15 Radix Glycyrrhizae 7.5
Chinese patent medicine manufacture method processing routinely cleans the first-class medical material of quality, removes impurity, and the pulverizing that is mixed is fully stirred, sterilization.Peroral dosage form is made the watered pill, the every clothes of adult 8.0 grams, and every day 2 to 3 times is oral, and children's looks age, monthly age and takes the circumstances into consideration decrement and take.The umbilical external application dosage form is packed dried medicated powder 5.0 with the aseptic cotton gauze and is restrained into ball-shaped, and the time spent gets the desensitization rubber plaster and fixes a ball in umbilical part, make rubber plaster reach sealing purpose.Changed once in 24 hours.
All affection by exopathogenic cold-wind human bodies must then be joined the army to fur earlier and be defended, so with Herba Schizonepetae, Herba Moslae, the Radix Angelicae Dahuricae, Herba Coriandri relieving the exterior syndrome with drugs of pungent in flavor and warm in nature, its pathogenic factor in the exterior looses; Radix Bupleuri is worked hard, is slightly cold, and is apt to discongest the heresy of half exterior and half interior, can cooperate preceding four flavors to induce sweat, and deep heresy is passed through inside; Radix Scutellariae, Fructus Forsythiae bitter cold, heat-clearing and toxic substances removing, it is cruel to make exopathogen execute together with fire, and also can restrict hot temperature disperse too unlikely, in order to avoid the hyperhidrosis impairment of YANG: the Radix Glycyrrhizae pathogenic fire purging, transfer medicine and in, make pathogen leave and healthy energy does not have wound.
Because the hot warm flavour of a drug amount of the present invention plays a leading role greatly, it is fine to control the anemofrigid cold effect.Because the combination of relieving the exterior syndrome with drugs of pungent in flavor and warm in nature flavour of a drug and clearing up internal heat by using drugs of bitter in taste and cold in nature detoxifcation flavour of a drug has the Radix Bupleuri help that is slightly cold again, control the affection due to external wind and heat flu and also take effect repeatedly again.Ailment said due to cold or exposure is first of the six climate exopathogens, once ailment said due to cold or exposure leaves, other pathogen such as cold and heat is difficult help, is easy to naturally answer medicine and separates.
The inventor is engaged in two more than ten years of tcm clinical practice work, make with this invention control exterior syndrome existing two more than ten years history.For showing the therapeutic effect of medicine of the present invention to exterior syndrome, through 500 routine patients' clinical observation, effective percentage is 96.6%, cure rate 93.4%.Male's 135 examples wherein, women's 365 examples.Maximum 78 years old age, minimum full moon infant.Wherein wind-cold type accounts for 78%, wind heat and other type account for 22%.The wind and cold diseases caused by exogenous pathogenic factor account for the overwhelming majority throughout the year, and infant is more than half not oral, a umbilical external application.

Claims (2)

1. Chinese patent medicine for the treatment of exterior syndrome is characterized in that it is made up of the following weight proportion raw material:
Herba Moslae 30~40 Herba Schizonepetae 20~30 Herba Coriandris 10~20 Radixs Angelicae Dahuricae 20~30
Radix Bupleuri 10~20 Radix Scutellariaes 20~30 Fructus Forsythiaes 10~20 Radix Glycyrrhizae 5~10.
2. a kind of Chinese patent medicine for the treatment of exterior syndrome according to claim 1 is characterized in that the weight proportion of each raw material is:
Herba Moslae 35 Herba Schizonepetae 25 Herba Coriandris 15 Radixs Angelicae Dahuricae 25
Radix Bupleuri 15 Radix Scutellariaes 25 Fructus Forsythiaes 15 Radix Glycyrrhizae 7.5.
CN200710010760A 2007-03-24 2007-03-24 Chinese readymade medicine for treating exogenous disease Expired - Fee Related CN101023990B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200710010760A CN101023990B (en) 2007-03-24 2007-03-24 Chinese readymade medicine for treating exogenous disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200710010760A CN101023990B (en) 2007-03-24 2007-03-24 Chinese readymade medicine for treating exogenous disease

Publications (2)

Publication Number Publication Date
CN101023990A CN101023990A (en) 2007-08-29
CN101023990B true CN101023990B (en) 2010-05-19

Family

ID=38742832

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200710010760A Expired - Fee Related CN101023990B (en) 2007-03-24 2007-03-24 Chinese readymade medicine for treating exogenous disease

Country Status (1)

Country Link
CN (1) CN101023990B (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1448154A (en) * 2002-04-02 2003-10-15 刘景君 Medicine for treating exopathic disease and preparation process thereof
CN1491691A (en) * 2003-07-22 2004-04-28 王建春 Recipe composition of cold-resisting Chinese medicine sugar-less granular powder and tablet and preparing process
CN1733148A (en) * 2005-08-01 2006-02-15 刘安西 Quick release percutaneous absorption Chinese traditional medicine paster for reducing ever and curing cold
CN1907329A (en) * 2005-08-01 2007-02-07 朱瑞清 Children's rheum tablet and its preparation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1448154A (en) * 2002-04-02 2003-10-15 刘景君 Medicine for treating exopathic disease and preparation process thereof
CN1491691A (en) * 2003-07-22 2004-04-28 王建春 Recipe composition of cold-resisting Chinese medicine sugar-less granular powder and tablet and preparing process
CN1733148A (en) * 2005-08-01 2006-02-15 刘安西 Quick release percutaneous absorption Chinese traditional medicine paster for reducing ever and curing cold
CN1907329A (en) * 2005-08-01 2007-02-07 朱瑞清 Children's rheum tablet and its preparation

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
刘苏宝等.中医治疗外感发热临床研究近况.中国民族民间医药杂志2004年 第6期.2004,2004年(第6期),第326-328行.
刘苏宝等.中医治疗外感发热临床研究近况.中国民族民间医药杂志2004年 第6期.2004,2004年(第6期),第326-328行. *
周祯祥.感冒用药举要.湖北中医杂志24 4.2002,24(4),第38-39页.
周祯祥.感冒用药举要.湖北中医杂志24 4.2002,24(4),第38-39页. *

Also Published As

Publication number Publication date
CN101023990A (en) 2007-08-29

Similar Documents

Publication Publication Date Title
CN101366892A (en) Chinese medicinal composition for treating menorrhalgia
CN101816736B (en) Chinese medicament capsule for curing nasosinusitis
CN102920868B (en) Miao medicine for treating pancreatic diseases
CN102188661B (en) Traditional Chinese medicine for removing arthralgia and preparation method thereof
CN101804189B (en) Drug for treating primary dysmenorrhea
CN1115165C (en) Externally applied medicated wine for treating traumatic injury and rheumatism
CN101023990B (en) Chinese readymade medicine for treating exogenous disease
CN103768275A (en) Traditional Chinese medicinal hair growing fluid for treating alopecia seborrhoeica
CN102526418B (en) Drug for treating lumbar disc herniation and preparation method thereof
CN102258602B (en) Chinese medicinal composition for treating rheumatism and rheumatoid and preparation method thereof
CN101810831B (en) Medicament for treating gynecological diseases
CN103520495A (en) Pure traditional Chinese medicine composition for treatment of necrotic enteritis of poultry and preparation method thereof
CN102824456A (en) Specific medicine for treating animal aftosa
CN102274418A (en) Medicinal powder for preventing and treating anemofrigid cold of livestock and poultry
CN105362999A (en) Traditional Chinese medicine preparation for preventing and treating infantile repeated cold and preparation method thereof
CN100556422C (en) The injection and the method for making thereof of treatment hyperosteogeny
CN1049599C (en) Medicine for treatment of thromboangiitis obliterans
CN104826043A (en) Chinese medicinal formula for treating crural sprain
CN101912501B (en) Medicament for treating ormarthritis and preparation method thereof
CN104147263A (en) Traditional Chinese medicine for treating neurodermatitis
CN1724021A (en) Traditional Chinese medicine for treating rheumatoid disease
CN102188639A (en) Medicament for treating rhinitis and preparation method thereof
CN104138543A (en) Traditional Chinese medicine for treating epididymitis
CN110624090A (en) External dysmenorrhea conditioning bag and using method thereof
CN103566110A (en) Bonesetting traditional Chinese medicine

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
DD01 Delivery of document by public notice
DD01 Delivery of document by public notice

Addressee: Liu Jingjun

Document name: payment instructions

DD01 Delivery of document by public notice
DD01 Delivery of document by public notice

Addressee: Liu Jingjun

Document name: Notice of Termination of Patent Rights

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20100519